These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29217318)

  • 1. GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome.
    Rigamonti AE; Crinò A; Bocchini S; Convertino A; Bidlingmaier M; Haenelt M; Tamini S; Cella SG; Grugni G; Sartorio A
    Growth Horm IGF Res; 2018 Apr; 39():13-18. PubMed ID: 29217318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
    Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
    Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
    Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
    Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulated GH levels during the transition phase in Prader-Willi syndrome.
    Grugni G; Marzullo P; Delvecchio M; Iughetti L; Licenziati MR; Osimani S; Ragusa L; Salvatoni A; Sartorio A; Stagi S; Crinò A;
    J Endocrinol Invest; 2021 Jul; 44(7):1465-1474. PubMed ID: 33095904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A; Donaubauer J; Kratzsch J; Pfaeffle R; Hirsch W; Kiess W; Keller E
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
    Valetto MR; Bellone J; Baffoni C; Savio P; Aimaretti G; Gianotti L; Arvat E; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon stimulation test to assess growth hormone status in Prader-Willi syndrome.
    Casamitjana L; Giménez-Palop O; Corripio R; Pareja R; Berlanga E; Rigla M; Oliva JC; Caixàs A
    J Endocrinol Invest; 2021 Mar; 44(3):621-629. PubMed ID: 32720093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Moro D; Bettio D; De Medici C; Morabito F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):769-75. PubMed ID: 9713567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology.
    Corrias A; Bellone J; Beccaria L; Bosio L; Trifirò G; Livieri C; Ragusa L; Salvatoni A; Andreo M; Ciampalini P; Tonini G; Crinò A
    J Endocrinol Invest; 2000 Feb; 23(2):84-9. PubMed ID: 10800760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bertocco P; Marzullo P
    Am J Med Genet A; 2009 Feb; 149A(4):726-31. PubMed ID: 19267411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome.
    Di Giorgio G; Grugni G; Fintini D; Bocchini S; Spera S; Cuttini M; Cappa M; Crinò A
    Horm Res Paediatr; 2014; 81(3):189-95. PubMed ID: 24503962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Morabito F
    J Endocrinol Invest; 2001 May; 24(5):340-8. PubMed ID: 11407654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls.
    Grugni G; Marostica E; Crinò A; Marzullo P; De Nicolao G; Sartorio A
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):224-31. PubMed ID: 23301953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.